Switzerland· 65570007
Jardiance Met 12.5 mg/500 mg, Filmtabletten
A metformin and empagliflozin product containing empagliflozinum, metformini hydrochloridum, registered in Switzerland by Boehringer Ingelheim (Schweiz) GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 13 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Metformin and empagliflozin is registered in 13 of 19 countries.
Countries holding a registration under ATC A10BD20 (metformin and empagliflozin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Metformin and empagliflozin · ATC A10BD20
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- empagliflozinum, metformini hydrochloridum
- Manufacturer
- Boehringer Ingelheim (Schweiz) GmbH
- Country
- Switzerland (CH)
- ATC code
- A10BD20
- ATC class
- Metformin and empagliflozin
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metformin and empagliflozin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMEMPOGLYNKrka, d.d., Novo mesto, Novo mesto
- IcelandApprefAdalvo Limited
- United StatesSynjardyBoehringer Ingelheim Pharmaceuticals, Inc.
- NetherlandsAppref 12,5 mg/1000 mg filmomhulde tablettenMeren Pharma B.V.
- IrelandEmpagliflozin/Metformin Krka 12.5 mg/1000 mg film-coated tabletsKRKA, d.d., Novo mesto
- United KingdomSynjardy 12.5mg/1000mg tabletsCST Pharma Ltd
- CanadaSYNJARDYBOEHRINGER INGELHEIM (CANADA) LTD LTEE
- FinlandSynjardyBoehringer Ingelheim Pharma GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Empagliflozin/Metformin Hcs
- Belgium · Empagliflozine/Metformine Hcl Hcs
- Bulgaria · Empafel Met 5 Mg/850 Mg, Емпафел Мет
- Cyprus · Empagliflozin/Metformin Tad
- Czechia · Mempoglyn
- Denmark · Empagliflozin/Metformin Krka
- Estonia · Mempoglyn
- Spain · Empagliflozina/Metformina Krka
- Greece · Mempoglyn
- Croatia · Mempoglyn
- Hungary · Mempoglyn
- Ireland · Empagliflozin/Metformin Krka
- Iceland · Appref, Empagliflozin-Metformin Adalvo
- Liechtenstein · Synjardy
- Lithuania · Mempoglyn
- Luxembourg · Empagliflozin/Metformin Hcl Ab
- Latvia · Mempoglyn
- Malta · Appref, Empagliflozin-Metformin Adalvo
- Netherlands · Appref, Empagliflozine/Metformine Hcl Hcs
- Norway · Empagliflozin/Metformin Krka, Synjardy
- Portugal · Empagliflozina + Metformina Aurobindo, Empagliflozina + Metformina Generis
- Romania · Mempoglyn
- Slovenia · Emameten, Empagliflozin/Metformin Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/faf07872-d2ef-4dfe-90b8-ba89299eb46a GET /v1/drugs/faf07872-d2ef-4dfe-90b8-ba89299eb46a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about metformin and empagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.